SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Clinical: Speech Therapy and Communication Aids in Corticobasal Syndro

clinical 947 words KG: ent-dise-67965886

section:diseases kind:clinical-feature topic:cbs topic:rehabilitation

Contents

Speech Therapy and Communication Aids in Corticobasal Syndrome

Knowledge Graph

Related Hypotheses (25)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 Purinergic Signaling Polarization Control
Score: 0.55 Mechanosensitive Ion Channel Reprogramming
Score: 0.51 Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68

Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 PARP1 Inhibition Therapy
Score: 0.58 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51 Ganglioside Rebalancing Therapy
Score: 0.50 Lysosomal Calcium Channel Modulation Therapy
Score: 0.49 Orexin-Microglia Modulation Therapy
Score: 0.49 Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48 Complement C1q Mimetic Decoy Therapy
Score: 0.48 TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47 Arginine Methylation Enhancement Therapy
Score: 0.46 Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45 Hypocretin-Neurogenesis Coupling Therapy
Score: 0.45 HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.44 R-Loop Resolution Enhancement Therapy
Score: 0.43 Glial Glycocalyx Remodeling Therapy
Score: 0.41 SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.39 Quantum Coherence Disruption in Cellular Communication
Score: 0.34

Related Analyses (22)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived

Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived

Related Experiments (14)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Down Syndrome Alzheimer's Disease: Mechanisms and Therapeuti
clinical · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40

Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40 Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40 Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40 Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40 Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40 Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40

See Also (15)

Yoga Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses YAP/TEAD Pathway Modulators for Neurodegeneration
therapeutic · Pages share 4 hypotheses Wnt Signaling Modulators for Neurodegeneration
therapeutic · Pages share 4 hypotheses vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 4 hypotheses Vitamin B Complex Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses

VIP/VPAC Receptor Modulators for Neurodegeneration
therapeutic · Pages share 4 hypotheses Vestibular and Balance Therapy for CBS/PSP
therapeutic · Pages share 4 hypotheses VEGF and Angiogenesis Therapy
therapeutic · Pages share 4 hypotheses Urolithin A for Neurodegeneration
therapeutic · Pages share 4 hypotheses Urolithin A for Neurodegeneration
therapeutic · Pages share 4 hypotheses tudca-udca-neurodegeneration
therapeutic · Pages share 4 hypotheses TRPM8 Agonists for Neurodegeneration
therapeutic · Pages share 4 hypotheses Triple Incretin Agonists (GLP-1/GIP/Glucagon) for Neuro
therapeutic · Pages share 4 hypotheses TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses Transcranial Magnetic Stimulation Therapy for Neurodege
therapeutic · Pages share 4 hypotheses

SciDEX — scidex.ai — Dashboard | Atlas